These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37633160)

  • 1. Minor physical anomalies may be related to treatment resistance in patients with schizophrenia.
    Uğurpala C; Berberoğlu E; Özkan U; Genç SA; Tanrıverdi NÇ; İnhanlı D; Ali C; Üçok A
    Asian J Psychiatr; 2023 Oct; 88():103729. PubMed ID: 37633160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor physical anomalies and craniofacial measures in patients with treatment-resistant schizophrenia.
    Lin AS; Chang SS; Lin SH; Peng YC; Hwu HG; Chen WJ
    Psychol Med; 2015 Jul; 45(9):1839-50. PubMed ID: 25515974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls.
    Compton MT; Bollini AM; McKenzie Mack L; Kryda AD; Rutland J; Weiss PS; Bercu Z; Esterberg ML; Walker EF
    Schizophr Res; 2007 Aug; 94(1-3):64-73. PubMed ID: 17512173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.
    Nakajima S; Takeuchi H; Plitman E; Fervaha G; Gerretsen P; Caravaggio F; Chung JK; Iwata Y; Remington G; Graff-Guerrero A
    Schizophr Res; 2015 May; 164(1-3):164-75. PubMed ID: 25684554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis.
    Mizuno Y; McCutcheon RA; Brugger SP; Howes OD
    Neuropsychopharmacology; 2020 Mar; 45(4):622-631. PubMed ID: 31766049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation.
    Suzuki T; Remington G; Mulsant BH; Uchida H; Rajji TK; Graff-Guerrero A; Mimura M; Mamo DC
    Psychiatry Res; 2012 May; 197(1-2):1-6. PubMed ID: 22429484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
    Thompson PA; Buckley PF; Meltzer HY
    J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.
    de Bartolomeis A; Prinzivalli E; Callovini G; D'Ambrosio L; Altavilla B; Avagliano C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():356-366. PubMed ID: 28887181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the ITIH3 rs2535629 variant in antipsychotic response.
    Brandl EJ; Lett TA; Chowdhury NI; Tiwari AK; Bakanidze G; Meltzer HY; Potkin SG; Lieberman JA; Kennedy JL; Müller DJ
    Schizophr Res; 2016 Oct; 176(2-3):131-135. PubMed ID: 27396837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study.
    Lin AS; Chan HY; Peng YC; Chen WJ
    BMC Psychiatry; 2019 Jul; 19(1):220. PubMed ID: 31299940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of blonanserin for patients with drug treatment-resistant schizophrenia and dopamine supersensitivity: A retrospective analysis.
    Tachibana M; Niitsu T; Watanabe M; Hashimoto T; Kanahara N; Ishikawa M; Iyo M
    Asian J Psychiatr; 2016 Dec; 24():28-32. PubMed ID: 27931902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics.
    Medina-Hernández V; Ramos-Loyo J; Luquin S; Sánchez LF; García-Estrada J; Navarro-Ruiz A
    J Psychiatr Res; 2007 Oct; 41(8):652-8. PubMed ID: 16600300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis.
    Kimura H; Kanahara N; Komatsu N; Ishige M; Muneoka K; Yoshimura M; Yamanaka H; Suzuki T; Komatsu H; Sasaki T; Hashimoto T; Hasegawa T; Shiina A; Ishikawa M; Sekine Y; Shiraishi T; Watanabe H; Shimizu E; Hashimoto K; Iyo M
    Schizophr Res; 2014 May; 155(1-3):52-8. PubMed ID: 24667073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.